High expression of α‐SMA (88.9%, 32/36) and pSMAD2/3 (proportion 3/4: 30/36; 83.3%, intensity 2/3: 29/36; 80.6%) were confirmed in a high proportion of tumours (Figure 3). This evidence concerns the gene ACTA1 and neoplasm.